A national database study linked intervals between staged bilateral TKAs below approximately 10–11 weeks to higher 90-day major adverse event and VTE rates.
In the double-blind EPCAT III RCT, aspirin alone was noninferior to 5 days of rivaroxaban followed by aspirin for preventing symptomatic VTE after total hip or knee arthroplasty, with no clinically relevant...
Emerging research explores how a wearable device may identify infection before symptoms appear, which treatments reduce hospitalizations, and who remains most at risk.
Patients who used statins for at least 4 weeks prior to total hip arthroplasty experienced significantly lower rates of venous thromboembolism within 90 days postoperatively. No significant differences were...
In a retrospective study spanning nearly two decades, researchers found a low incidence of venous thromboembolism following colorectal procedures for pelvic floor and motility disorders, with the highest...
A multicenter study revealed significant variations in the administration of postpartum venous thromboembolism (VTE) prophylaxis and highlighted key risk factors influencing its use.
This COVID-19 roundup includes coverage on the latest estimated number of adults with long COVID, WHO’s updated terminology for pathogens that transmit through the air, how COVID-19 vaccination reduces the...
In this COVID-19 roundup, we discuss the expansion of eligible populations for a COVID-19 booster dose, approval of a nonprescription respiratory infection test, thrombosis risk after COVID-19 infections,...
Patients with inflammatory bowel disease have an increased risk for venous thromboembolism during hospitalization. Researchers in Ontario, Canada, sought to determine whether the risk continues after...
